Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.

Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly J, Fischer MA, Kesselheim AS, Gagne JJ.

BMJ. 2018 Apr 3;361:k1180. doi: 10.1136/bmj.k1180.

2.

Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs.

Cheng N, Rahman MM, Alatawi Y, Qian J, Peissig PL, Berg RL, Page CD, Hansen RA.

Drug Saf. 2018 Apr;41(4):363-376. doi: 10.1007/s40264-017-0624-0.

PMID:
29196989
3.

Development and validation of a tool to assess knowledge and attitudes towards generic medicines among students in Greece: The ATtitude TOwards GENerics (ATTOGEN) questionnaire.

Domeyer PJ, Aletras V, Anagnostopoulos F, Katsari V, Niakas D.

PLoS One. 2017 Nov 29;12(11):e0188484. doi: 10.1371/journal.pone.0188484. eCollection 2017.

4.

"No generics, Doctor!" The perspective of general practitioners in two French regions.

Riner B, Bussy A, Hélène-Pelage J, Moueza N, Lamy S, Carrère P.

BMC Health Serv Res. 2017 Nov 9;17(1):707. doi: 10.1186/s12913-017-2682-5.

5.

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.

Wouters OJ, Kanavos PG, McKEE M.

Milbank Q. 2017 Sep;95(3):554-601. doi: 10.1111/1468-0009.12279.

PMID:
28895227
6.

Influencers of generic drug utilization: A systematic review.

Howard JN, Harris I, Frank G, Kiptanui Z, Qian J, Hansen R.

Res Social Adm Pharm. 2017 Aug 4. pii: S1551-7411(17)30479-5. doi: 10.1016/j.sapharm.2017.08.001. [Epub ahead of print] Review.

PMID:
28814375
7.

Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city.

Guttier MC, Silveira MPT, Luiza VL, Bertoldi AD.

Rev Saude Publica. 2017 Jun 26;51:59. doi: 10.1590/S1518-8787.2017051006786.

8.

Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department.

Das M, Choudhury S, Maity S, Hazra A, Pradhan T, Pal A, Roy RK.

J Nat Sci Biol Med. 2017 Jan-Jun;8(1):26-31. doi: 10.4103/0976-9668.198351.

9.

Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.

Hansen RA, Qian J, Berg R, Linneman J, Seoane-Vazquez E, Dutcher SK, Raofi S, Page CD, Peissig P.

Pharmacotherapy. 2017 Apr;37(4):429-437. doi: 10.1002/phar.1908. Epub 2017 Mar 20.

10.

Comparison of Outcomes Following a Switch From a Brand to an Authorized Versus Independent Generic Drug.

Hansen RA, Qian J, Berg RL, Linneman JG, Seoane-Vazquez E, Dutcher S, Raofi S, Page CD, Peissig PL.

Clin Pharmacol Ther. 2018 Feb;103(2):310-317. doi: 10.1002/cpt.591. Epub 2017 Oct 10.

11.

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

Godman B, Shrank W, Wettermark B, Andersen M, Bishop I, Burkhardt T, Garuolienè K, Kalaba M, Laius O, Joppi R, Sermet C, Schwabe U, Teixeira I, Tulunay FC, Wendykowska K, Zara C, Gustafsson LL.

Pharmaceuticals (Basel). 2010 Aug 5;3(8):2470-2494. Review.

12.

Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures.

Donohue JM, Normand SL, Horvitz-Lennon M, Men A, Berndt ER, Huskamp HA.

J Ment Health Policy Econ. 2016 Jun;19(2):69-78.

13.

Perception and attitude of physicians toward local generic medicines in Saudi Arabia: A questionnaire-based study.

Salhia HO, Ali A, Rezk NL, El Metwally A.

Saudi Pharm J. 2015 Sep;23(4):397-404. doi: 10.1016/j.jsps.2015.01.014. Epub 2015 Jan 16.

14.

A cross-sectional survey of pharmacists to understand their personal preference of brand and generic over-the-counter medications used to treat common health conditions.

Patel M, Slack M, Cooley J, Bhattacharjee S.

J Pharm Policy Pract. 2016 Apr 21;9:17. doi: 10.1186/s40545-016-0066-6. eCollection 2016.

15.

Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome.

Jackevicius CA, Tu JV, Krumholz HM, Austin PC, Ross JS, Stukel TA, Koh M, Chong A, Ko DT.

J Am Heart Assoc. 2016 Apr 19;5(4):e003350. doi: 10.1161/JAHA.116.003350.

16.

Capsule Commentary on Kesselheim et. al., Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey.

Kaplan CM.

J Gen Intern Med. 2016 Jun;31(6):647. doi: 10.1007/s11606-016-3670-x. No abstract available.

17.

Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey.

Kesselheim AS, Gagne JJ, Franklin JM, Eddings W, Fulchino LA, Avorn J, Campbell EG.

J Gen Intern Med. 2016 Jun;31(6):609-14. doi: 10.1007/s11606-016-3612-7. Epub 2016 Feb 16.

18.

Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review.

Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ.

BMJ Open. 2015 Dec 15;5(12):e008915. doi: 10.1136/bmjopen-2015-008915. Review.

19.

Generic versus brand-name drugs used in cardiovascular diseases.

Manzoli L, Flacco ME, Boccia S, D'Andrea E, Panic N, Marzuillo C, Siliquini R, Ricciardi W, Villari P, Ioannidis JP.

Eur J Epidemiol. 2016 Apr;31(4):351-68. doi: 10.1007/s10654-015-0104-8. Epub 2015 Nov 30. Review.

20.

Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.

Wouters OJ, Kanavos PG.

Bull World Health Organ. 2015 Sep 1;93(9):606-13. doi: 10.2471/BLT.14.148742. Epub 2015 Jun 18.

Supplemental Content

Support Center